{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:17:13Z","timestamp":1780928233247,"version":"3.54.1"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.27134","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T16:04:41Z","timestamp":1660925081000},"page":"e2227134","source":"Crossref","is-referenced-by-count":5,"title":["Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical Practice"],"prefix":"10.1001","volume":"5","author":[{"given":"Sanket S.","family":"Dhruva","sequence":"first","affiliation":[{"name":"Section of Cardiology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco"},{"name":"San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Zhang","sequence":"additional","affiliation":[{"name":"MedTech Epidemiology and Real-World Data Sciences, Office of the Chief Medical Officer, Johnson & Johnson, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Chen","sequence":"additional","affiliation":[{"name":"Mercy Research, Mercy Health, Chesterfield, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Noseworthy","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit A.","family":"Doshi","sequence":"additional","affiliation":[{"name":"Mercy Clinic, Mercy Health, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolade M.","family":"Agboola","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeph","family":"Herrin","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Cafri","sequence":"additional","affiliation":[{"name":"MedTech Epidemiology and Real-World Data Sciences, Office of the Chief Medical Officer, Johnson & Johnson, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Collison Farr","sequence":"additional","affiliation":[{"name":"Mercy Research, Mercy Health, Chesterfield, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keondae R.","family":"Ervin","sequence":"additional","affiliation":[{"name":"National Evaluation System for Health Technology Coordinating Center, Medical Device Innovation Consortium, Arlington, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Center for Outcomes Research and Evaluation, Yale\u2013New Haven Hospital, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Coplan","sequence":"additional","affiliation":[{"name":"MedTech Epidemiology and Real-World Data Sciences, Office of the Chief Medical Officer, Johnson & Johnson, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Joseph P.","family":"Drozda","sequence":"additional","affiliation":[{"name":"Mercy Research, Mercy Health, Chesterfield, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"issue":"4","key":"zoi220768r1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1056\/NEJMcp2023658","article-title":"Atrial fibrillation.","volume":"384","author":"Michaud","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"zoi220768r2","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1161\/CIR.0000000000000041","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"zoi220768r3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1056\/NEJMoa050955","article-title":"Circumferential pulmonary-vein ablation for chronic atrial fibrillation.","volume":"354","author":"Oral","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi220768r4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"issue":"22","key":"zoi220768r5","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/eurheartj\/ehu001","article-title":"The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association.","volume":"35","author":"Arbelo","year":"2014","journal-title":"Eur Heart J"},{"issue":"25","key":"zoi220768r6","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1161\/01.CIR.0000134694.78653.B6","article-title":"Post-market approval surveillance: a call for a more integrated and comprehensive approach.","volume":"109","author":"Mehran","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"zoi220768r9","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1097\/MLR.0b013e31827da819","article-title":"Feasibility of proactive medical device surveillance: the VA Clinical Assessment Reporting and Tracking (CART) program.","volume":"51","author":"Tsai","year":"2013","journal-title":"Med Care"},{"issue":"18","key":"zoi220768r10","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2010.1633","article-title":"Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices.","volume":"304","author":"Resnic","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"zoi220768r11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.006105","article-title":"Active surveillance of the Implantable Cardioverter-Defibrillator Registry for defibrillator lead failures.","volume":"13","author":"Resnic","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"zoi220768r12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa1516333","article-title":"Registry-based prospective, active surveillance of medical-device safety.","volume":"376","author":"Resnic","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi220768r13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1161\/CIRCOUTCOMES.111.962621","article-title":"Early detection of an underperforming implantable cardiovascular device using an automated safety surveillance tool.","volume":"5","author":"Hauser","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"zoi220768r14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsit-2021-000089","article-title":"Feasibility of using real-world data in the evaluation of cardiac ablation catheters: a test-case of the National Evaluation System for Health Technology Coordinating Center.","volume":"3","author":"Dhruva","year":"2021","journal-title":"BMJ Surg Interv Health Technol"},{"issue":"10","key":"zoi220768r15","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1093\/jamia\/ocab117","article-title":"Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: a fit-for-purpose informatics analysis report.","volume":"28","author":"Jiang","year":"2021","journal-title":"J Am Med Inform Assoc"},{"issue":"8","key":"zoi220768r18","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jacep.2020.04.024","article-title":"Persistent atrial fibrillation ablation with contact force-sensing catheter: the prospective multicenter PRECEPT Trial.","volume":"6","author":"Mansour","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"10","key":"zoi220768r19","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"issue":"13","key":"zoi220768r20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial.","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"zoi220768r21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure.","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"issue":"19","key":"zoi220768r22","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation.","volume":"372","author":"Verma","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi220768r23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsit-2020-000058","article-title":"Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology.","volume":"2","author":"Akar","year":"2020","journal-title":"BMJ Surg Interv Health Technol"},{"issue":"11","key":"zoi220768r24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jacep.2017.05.005","article-title":"Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013.","volume":"3","author":"Hosseini","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"19","key":"zoi220768r25","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.113.003862","article-title":"In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.","volume":"128","author":"Deshmukh","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"zoi220768r26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10840-020-00734-w","article-title":"Real-world safety of catheter ablation for atrial fibrillation with contact force or cryoballoon ablation.","volume":"60","author":"Natale","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"issue":"2","key":"zoi220768r27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/19466315.2019.1647873","article-title":"Some considerations on design and analysis plan on a nonrandomized comparative study using propensity score methodology for medical device premarket evaluation.","volume":"12","author":"Lu","year":"2019","journal-title":"Stat Biopharm Res"},{"issue":"25","key":"zoi220768r28","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"2","key":"zoi220768r29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/19466315.2021.1994460","article-title":"Selecting an optimal design for a non-randomized comparative study: a comment on \u201cSome considerations on design and analysis plan on a nonrandomized comparative study utilizing propensity score methodology for medical device premarket evaluation.\u201d.","volume":"14","author":"Cafri","year":"2022","journal-title":"Stat Biopharm Res"},{"issue":"20","key":"zoi220768r30","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.","volume":"24","author":"Xie","year":"2005","journal-title":"Stat Med"},{"issue":"12","key":"zoi220768r34","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jamainternmed.2020.3214","article-title":"Clinical evidence supporting US Food and Drug Administration clearance of novel therapeutic devices via the de novo pathway between 2011 and 2019.","volume":"180","author":"Johnston","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"12","key":"zoi220768r35","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.mayocp.2020.04.013","article-title":"Mandatory registration and results reporting of real-world evidence studies of FDA-regulated medical products.","volume":"95","author":"Dhruva","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"zoi220768r36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/pds.4297","article-title":"Good practices for real-world data studies of treatment and\/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.","volume":"26","author":"Berger","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"zoi220768r7","year":"2016"},{"key":"zoi220768r8","unstructured":"US Food and Drug Administration. Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. Published August 31, 2017. Accessed March 12, 2022. https:\/\/www.fda.gov\/media\/99447\/download"},{"key":"zoi220768r16","unstructured":"US Food and Drug Administration. Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program. Guidance for industry and Food and Drug Administration Staff. January 6, 2021. Accessed March 12, 2022. https:\/\/www.fda.gov\/media\/114034\/download"},{"key":"zoi220768r17","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigiliance. Accessed March 12, 2022. https:\/\/www.encepp.eu\/index.shtml"},{"key":"zoi220768r31","unstructured":"Jaeckel L. The Infinitesimal Jackknife. Bell Laboratories; 1972. Accessed March 12, 2022. http:\/\/faculty.washington.edu\/fscholz\/Reports\/InfinitesimalJackknife.pdf"},{"key":"zoi220768r32","unstructured":"US Food and Drug Administration. Examples of Real-World Evidence (RWE) Used in Medical Device Regulatory Decisions. Accessed March 12, 2022. https:\/\/www.fda.gov\/media\/146258\/download"},{"key":"zoi220768r33","unstructured":"Institute of Medicine. Medical Devices and the Public\u2019s Health: The FDA 510(k) Clearance Process at 35 Years. Published 2011. Accessed March 12, 2022. https:\/\/www.nap.edu\/catalog\/13150\/medical-devices-and-the-publics-health-the-fda-510k-clearance"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2795250\/dhruva_2022_oi_220768_1659713297.75043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T16:04:47Z","timestamp":1660925087000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2795250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.27134","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]}}}